Woroud Nasser Al-Sulimmani

Dr. Woroud Nasser Al-Sulimmani

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2025 in International Dental Journal
Verified
Journal Article
Open access
WAWoroud Nasser Al-Sulimmani
Woroud Nasser Al-Sulimmani
AAAsmaa Al-Rasheed
Asmaa Al-Rasheed
HAHebah Al-Daraan
Hebah Al-Daraan
MAMuna Al-Mutairi
Muna Al-Mutairi
Yash BrahmbhattYash Brahmbhatt
Yash Brahmbhatt
HAHend Al-Qaderi
Hend Al-Qaderi
This systematic review and meta-analysis were conducted to compare the failure risk between amalgam and composite resin materials in permanent posterior teeth. Study eligibility requirements included clinical trials and observational studies with at least 12 months of follow-up. English-language studies from 1990 onwards were the only studies included. This review follows the Cochrane Handbook for Systematic Reviews of Interventions and the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Our search strategy included using the following databases: PubMed, Cochrane, and Google Scholar. The primary outcome was restoration failures, defined as restoration replacements, tooth and restoration fractures, secondary caries, postoperative sensitivity, and toothaches. We conducted a random-effects meta-analysis to determine the risk ratio (RR) of the included studies, and publication bias was assessed. The Cochrane Risk of Bias tool was employed to evaluate the quality of the clinical trials, while the Newcastle-Ottawa scale was used to assess the quality of other studies. The results were derived from 13 studies. The failure proportion for amalgam ranged from 0% to 50.0%, while that of composite resin restorations ranged from 0% to 62.7%. The meta-analysis did not find any statistically significant difference in failure risk between amalgam and composite resin restorations (RR: 0.96, 95% confidence intervals: 0.68-1.34). The Egger's test results did not show any significant evidence of publication bias in the meta-analysis (P > .05). This review did not reveal any statistically significant difference in the RR between composite resin and amalgam restorations. However, in their analyses, the 13 studies used varying definitions of failure and did not account for some important factors that might have influenced restoration failures. Future reviews need to account for other influential variables that contributed to restoration failures.

2 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
RGRipple Garg
Ripple Garg
SPSarah Pagni
Sarah Pagni
AAAhmad Alkandari
Ahmad Alkandari
AAAbrar Alkhesaili
Abrar Alkhesaili
NANouf Alsheredah
Nouf Alsheredah
HAHend Alqaderi
Hend Alqaderi
Metabolic syndrome (MetS) is a global health concern characterized by a cluster of metabolic abnormalities, including central obesity, hypertension, hyperglycemia, and dyslipidemia, which increase the risk of cardiovascular disease and type 2 diabetes. This systematic review and meta-analysis aimed to assess the diagnostic value of salivary C-reactive protein (CRP) as a non-invasive biomarker for MetS. A comprehensive search of PubMed, Cochrane Library, and Web of Science was conducted through December 2024. Eligible studies reported salivary CRP levels in individuals with and without MetS. Two independent reviewers extracted data on study design, demographics, CRP measurement methods, and diagnostic criteria for MetS. Meta-analyses were performed using random-effects models to calculate pooled standardized mean differences (SMDs) with 95% confidence intervals. Among 863 records screened, 19 studies involving 3,157 participants met the inclusion criteria. The pooled results showed significantly higher salivary CRP levels in individuals with MetS compared to controls (Hedges’ g = 1.02; 95% CI: | 0.23, 1.81] P = 0.01). High between-study heterogeneity was observed (I² = 98.91%, P < 0.001), and funnel plot asymmetry suggested potential publication bias or underlying heterogeneity. These findings suggest that salivary CRP may serve as a promising non-invasive biomarker for detecting metabolic syndrome.

2 March 2026 in Life
Verified
Journal Article
Open access
PDF file
MKMohammad Khalfan
Mohammad Khalfan
Yash BrahmbhattYash Brahmbhatt
Yash Brahmbhatt
SPSarah Pagni
Sarah Pagni
RGRipple Garg
Ripple Garg
AAAhmad A. Alkandari
Ahmad A. Alkandari
HAHend Alqaderi
Hend Alqaderi
Metabolic syndrome (MetS) is a cluster of conditions that rely on low-grade systemic inflammation and increase the risk of cardiovascular disease, type 2 diabetes, and stroke. C-reactive protein (CRP) has attracted growing interest in saliva as a non-invasive alternative to serum CRP testing, though existing evidence remains inconsistent. This systematic review and meta-analysis evaluated the association between salivary CRP levels and MetS and examined the consistency of findings across populations and methodological approaches. PubMed, the Cochrane Library, and Web of Science were searched up to December 2024 following PRISMA 2020 guidelines. Nineteen studies involving 3265 participants with and without MetS were included. Random-effects meta-analysis demonstrated higher salivary CRP levels in individuals with MetS compared with controls (SMD = 1.02; 95% CI −0.23 to 1.81), with substantial heterogeneity (I2 = 98.91%), reflecting variation in population characteristics and saliva collection protocols. Funnel plot assessment did not indicate publication bias. Despite considerable heterogeneity, pooled estimates suggest that individuals with MetS have higher levels of salivary CRP. Longitudinal studies employing standardized methodologies are required before its clinical implementation can be considered.